New Delhi As part of its effort to curb unethical marketing practices by pharma companies, Department of Pharmaceuticals and NITI Aayog member, health, Dr VK Paul reached out to lobby groups including Indian Drugs Manufacturers Association, Indian Pharmaceutical Alliance and Organization of Pharmaceutical Producers of India. To work on a detention plan.
At a meeting on the Uniform Code of Pharmaceuticals Marketing Practice, committee chairman Paul on Friday sought the views of pharmaceutical industry lobby groups. Following the directions of the Union Health Minister, the Center constituted a committee to frame an effective code of conduct for pharma companies. While representatives of the unions agreed with the government’s approach to curb such unethical practices, they had reservations on a proposed law to regulate the industry, as it could create “unnecessary discomfort and pain” for drug makers. was. “Pharma Association said they don’t. Want unethical marketing practices. Pharma lobby is fully in support of government and also monitoring actions of pharma companies. Discussion has not gone to this stage as to whether A separate law has to be made to regulate companies,” said a government official in Gyan.
“However, an association said that if a law is being framed, it should not create a compliance burden, but should be smooth. It should not create unnecessary hassle and pain for the industry on compliance,” he said. The meeting comes after allegations that Micro Labs Ltd., makers of Dolo 650, offered free prices. 1,000 crore to doctors during the pandemic for promoting anti-fever medicine, according to an IT department investigation.
catch all corporate news And updates on Live Mint. download mint news app to receive daily market update & Live business News,